Alcohol consumption among adults with a cancer diagnosis in the All of Us Research Program

IMPORTANCE: Alcohol consumption is associated with adverse oncologic and treatment outcomes among individuals with a diagnosis of cancer. As a key modifiable behavioral factor, alcohol consumption patterns among cancer survivors, especially during treatment, remain underexplored in the United States. OBJECTIVE: To comprehensively characterize alcohol consumption patterns among US cancer survivors. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from May 6, 2018, to January 1, 2022, from the National Institutes of Health All of Us Research Program, a diverse US cohort with electronic health record (EHR) linkage, and included 15 199 participants who reported a cancer diagnosis and 1839 patients among a subset with EHR data who underwent treatment within the past year of the baseline survey. Data analysis was performed from October 1, 2022, to January 31, 2023. MAIN OUTCOMES AND MEASURES: Prevalence of current drinking and of risky drinking behaviors, including exceeding moderate drinking (\u3e2 drinks on a typical drinking day), binge drinking (≥6 drinks on 1 occasion), and hazardous drinking (Alcohol Use Disorders Identification Test-Consumption [AUDIT-C] score ≥3 for women or ≥4 for men). RESULTS: This study included 15 199 adults (mean [SD] age at baseline, 63.1 [13.0] years; 9508 women [62.6%]) with a cancer diagnosis. Overall, 11 815 cancer survivors (77.7%) were current drinkers. Among current drinkers, 1541 (13.0%) exceeded moderate drinking, 2812 (23.8%) reported binge drinking, and 4527 (38.3%) engaged in hazardous drinking. After multivariable adjustment, survivors who were younger than 65 years, men, or of Hispanic ethnicity or who received a diagnosis before 18 years of age or ever smoked were more likely to exceed moderate drinking (aged \u3c50 years: odds ratio [OR], 2.90 [95% CI, 2.41-3.48]; aged 50-64 years: OR, 1.84 [95% CI, 1.58-2.15]; men: OR, 2.38 [95% CI, 2.09-2.72]; Hispanic ethnicity: OR, 1.31 [95% CI, 1.04-1.64]; aged \u3c18 years at diagnosis: OR, 1.52 [95% CI, 1.04-2.24]; former smokers: OR, 2.46 [95% CI, 2.16-2.79]; current smokers: OR, 4.14 [95% CI, 3.40-5.04]) or binge drink (aged \u3c50 years: OR, 4.46 [95% CI, 3.85-5.15]; aged 50-64 years: OR, 2.15 [95% CI, 1.90-2.43]; men: OR, 2.10 [95% CI, 1.89-2.34]; Hispanic ethnicity: OR, 1.31 [95% CI, 1.09-1.58]; aged \u3c18 years at diagnosis: OR, 1.71 [95% CI, 1.24-2.35]; former smokers: OR, 1.69 [95% CI, 1.53-1.87]; current smokers: OR, 2.27 [95% CI, 1.91-2.71]). Survivors with cancer diagnosed before 18 years of age or who ever smoked were more likely to be hazardous drinkers (aged \u3c18 years at diagnosis: OR, 1.52 [95% CI, 1.11-2.08]; former smokers: OR, 1.83 [95% CI, 1.68-1.99]; current smokers: OR, 2.13 [95% CI, 1.79-2.53]). Of 1839 survivors receiving treatment as captured in the EHR, 1405 (76.4%) were current drinkers, and among these, 170 (12.1%) exceeded moderate drinking, 329 (23.4%) reported binge drinking, and 540 (38.4%) engaged in hazardous drinking, with similar prevalence across different types of cancer treatment. CONCLUSIONS AND RELEVANCE: This cross-sectional study of a diverse US cohort suggests that alcohol consumption and risky drinking behaviors were common among cancer survivors, even among individuals receiving treatment. Given the adverse treatment and oncologic outcomes associated with alcohol consumption, additional research and implementation studies are critical in addressing this emerging concern among cancer survivors

Circulating markers of microbial translocation and host response to bacteria with risk of colorectal cancer: A prospective, nested case-control study in men

BACKGROUND: Gut microbial dysbiosis contributes to colorectal cancer (CRC) pathogenesis, possibly mediated in part by increased intestinal permeability to endotoxin lipopolysaccharide (LPS), microbial translocation, and subsequent endotoxemia and inflammation. However, epidemiologic evidence linking circulating markers of microbial translocation with CRC risk is limited. METHODS: We conducted a prospective, nested case-control study of 261 incident CRC cases and 261 controls (matched on age and time of blood draw) among 18,159 men with pre-diagnostic blood specimens in the Health Professionals Follow-Up Study (1993-2009). We examined three complementary markers of microbial translocation and host response to bacteria, including LPS-binding protein (LBP), soluble CD14 (sCD14), and endotoxincore antibody (EndoCAb) immunoglobulin M (IgM), with subsequent risk of CRC. Unconditional logistic regressions were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). FINDINGS: Pre-diagnostic circulating levels of sCD14 were associated with a higher risk of incident CRC. Compared to men in the lowest quartile, the multivariable OR was 1.90 (95% CI, 1.13-3.22) for men in the highest quartile (OR INTERPRETATION: Microbial translocation and host response to bacteria, as reflected by sCD14, is associated with risk of incident CRC in men. FUNDING: US National Institutes of Health

Bose condensation of upper-branch exciton-polaritons in a transferrable microcavity

Exciton-polaritons are composite bosonic quasiparticles arising from the strong coupling of excitonic transitions and optical modes. Exciton-polaritons have triggered wide exploration in the past decades not only due to their rich quantum phenomena such as superfluidity, superconductivity and quantized vortices but also due to their potential applications for unconventional coherent light sources and all-optical control elements. Here, we report the observation of Bose-Einstein condensation of the upper polariton branch in a transferrable WS$_2$ monolayer microcavity. Near the condensation threshold, we observe a nonlinear increase in upper polariton intensity. This sharp increase in intensity is accompanied by a decrease of the linewidth and an increase of the upper polariton temporal coherence, all of which are hallmarks of Bose-Einstein condensation. By simulating the quantum Boltzmann equation, we show that the upper polariton condensation only occurs for a particular range of particle density. We can attribute the creation of Bose condensation of the upper polariton to the following requirements: 1) the upper polariton is more excitonic than the lower one; 2) there is relatively more pumping in the upper branch; and 3) the conversion time from the upper to the lower polariton branch is long compared to the lifetime of the upper polaritons

Overcoming Coulomb Interaction Improves Free-Charge Generation and Thermoelectric Properties for n-Doped Conjugated Polymers

Molecular doping of organic semiconductors creates Coulombically bound charge and counterion pairs through a charge-transfer process. However, their Coulomb interactions and strategies to mitigate their effects have been rarely addressed. Here, we report that the number of free charges and thermoelectric properties are greatly enhanced by overcoming the Coulomb interaction in an n-doped conjugated polymer. Poly(2,2'-bithiazolothienyl-4,4',10,10'-tetracarboxydiimide) (PDTzTI) and the benchmark N2200 are n-doped by tetrakis (dimethylamino) ethylene (TDAE) for thermoelectrics. Doped PDTzTI exhibits similar to 10 times higher free-charge density and 500 times higher conductivity than doped N2200, leading to a power factor of 7.6 mu W m(-1) K-2 and ZT of 0.01 at room temperature. Compared to N2200, PDTzTI features a better molecular ordering and two-dimensional charge delocalization, which help overcome the Coulomb interaction in the doped state. Consequently, free charges are more easily generated from charge-counterion pairs. This work provides a strategy for improving n-type thermoelectrics by tackling electrostatic interactions

Activity Analysis of the Fuyu North Fault, China: Evidence from the Time-Series InSAR, GNSS, Seismic Reflection Profile, and Plate Dynamics

AbstractEarthquake disasters are frequent, and the seismic intensity is large in Northeast China. Earthquake activity research is an important aspect of earthquake disaster management. We chose some unconventional means to study fault activity, to find updated activity evidence. The Ms 5.3 earthquake occurred near the Fuyu North Fault (FNF) of China on May 27, 2018. Using the Sentinel-1B descending orbit data from 2016 to 2019, the line-of-sight (LOS) surface deformation in the study area was calculated by using the small baseline subset (SBAS) method. After transforming to the horizontal EW deformation, the variance component estimation method was used for fusion reconstruction with the EW data of the surrounding GNSS stations. The polynomial least square method is used to fit the fault slip rate of three EW data on the surface trace of the FNF. The fitting results of the three regions show that the horizontal eastward distribution rate of the upper plate is significantly greater than that of the lower plate, which is left-lateral clockwise torsion. The vertical structural deformation caused by the growth strata of the upper and lower plates of the upper SYT2 seismic profile of the FNF is quantitatively calculated, and the thrust rate of the upper plate is 0.2 mm/y relative to that of the lower plate. Based on the Li Siguang chessboard structure model, we found that the compression stress in the north-south direction is gradually weakened, and the compression stress in the east-west direction is gradually enhanced. Through the Coulomb stress analysis, the three events of CMT only induced the historical focal location of the surrounding part. The events of 2017 did not induce the events of 2018, but the events of 2019 were related to the induced effects of 2017 and 2018

Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers

Metabolic syndrome may contribute to the rising incidence of multiple gastrointestinal (GI) cancers in recent birth cohorts. However, other than hepatocellular carcinoma, the association between nonalcoholic fatty liver disease (NAFLD) and risk of non-liver GI cancers is unexplored. We prospectively examined the associations of NAFLD risk with GI cancers among 319,290 participants in the UK Biobank (2006-2019). Baseline risk for NAFLD was estimated using the Dallas Steatosis Index, a validated prediction tool. Multivariable Cox models were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) according to NAFLD risk categories: low (\u3c20%), intermediate (20%-49%), and high (≥50%). We also examined the associations by age of cancer diagnosis (earlier onset [\u3c60] vs. ≥60). A total of 273 incident liver cancer and 4789 non-liver GI cancer cases were diagnosed. Compared with individuals at low risk for NAFLD, those at high risk had 2.41-fold risk of liver cancer (RR = 2.41, 95% CI: 1.73-3.35) and 23% increased risk of non-liver GI cancers (RR = 1.23, 95% CI: 1.14-1.32) (all